Endosomal Toll-like receptors (TLR3, TLR7, TLR8, TLR9) (Endosomal TLRs)

Endosomal Toll-like receptors (TLRs) are a distinct subset of the Toll-like receptor family, specifically Toll-like receptor 3, Toll-like receptor 7, Toll-like receptor 8, and Toll-like receptor 9, which are localized within the endosomal compartments of various immune cells like dendritic cells and B cells (Fitzgerald & Kagan, 2020). These receptors function as critical sensors of the innate immune system, specialized in detecting nucleic acids such as double-stranded RNA, single-stranded RNA, and unmethylated CpG DNA (Kawai & Akira, 2010). Upon ligand binding, they initiate signaling cascades through adapter proteins MyD88 or TRIF, resulting in the robust production of type I interferons and other pro-inflammatory cytokines (Lind et al., 2022). While vital for clearing viral and bacterial infections, the chronic or inappropriate activation of these pathways by endogenous nucleic acids is strongly implicated in the development of autoimmune diseases, most notably systemic lupus erythematosus and dermatomyositis. Consequently, these receptors are high-priority therapeutic targets in modern drug development. Agonists are being developed as potent vaccine adjuvants and oncology treatments to enhance immune surveillance, while small-molecule antagonists like enpatoran and afimetoran are in clinical trials for treating autoimmune and inflammatory disorders by dampening overactive interferon signaling (Merck KGaA, 2023; BMS, 2023).

Other names

Nucleic acid-sensing Toll-like receptorsIntracellular Toll-like receptorsEndosomal TLR pathwayTLR3/7/8/9 signaling

Modulation of nucleic acid sensing pathways through either agonism to stimulate innate immune responses for oncology and vaccines, or antagonism to inhibit pathological cytokine production in autoimmune diseases.